APO Research, Inc.

APO RESEARCH · REPORT

PD-L1 and PIK3CA Testing Product

Selected research

Market Structure

Global PD-L1 and PIK3CA Testing Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global PD-L1 and PIK3CA Testing Product market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for PD-L1 and PIK3CA Testing Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PD-L1 and PIK3CA Testing Product include Roche, QIAGEN, Foundation Medicine, EntroGen, Amoy Diagnostics, Agilent Technologies and ACCB Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global PD-L1 and PIK3CA Testing Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PD-L1 and PIK3CA Testing Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PD-L1 and PIK3CA Testing Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PD-L1 and PIK3CA Testing Product market size, projected growth trends, production technologies, key applications, and end-use industries.

PD-L1 and PIK3CA Testing Product Segment by Company

Roche

QIAGEN

Foundation Medicine

EntroGen

Amoy Diagnostics

Agilent Technologies

ACCB Biotech

PD-L1 and PIK3CA Testing Product Segment by Type

PD-L1

PIK3CA

PD-L1 and PIK3CA Testing Product Segment by Application

Hospital

Diagnostic Center

Others

PD-L1 and PIK3CA Testing Product Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-L1 and PIK3CA Testing Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PD-L1 and PIK3CA Testing Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-L1 and PIK3CA Testing Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PD-L1 and PIK3CA Testing Product market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PD-L1 and PIK3CA Testing Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of PD-L1 and PIK3CA Testing Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of PD-L1 and PIK3CA Testing Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. PD-L1 and PIK3CA Testing Product Industry Trends Table 2. PD-L1 and PIK3CA Testing Product Industry Drivers Table 3. PD-L1 and PIK3CA Testing Product Industry Opportunities and Challenges Table 4. PD-L1 and PIK3CA Testing Product Industry Restraints Table 5. Global PD-L1 and PIK3CA Testing Product Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Manufacturers (2021-2026) Table 7. Global PD-L1 and PIK3CA Testing Product Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Manufacturers Table 9. Global PD-L1 and PIK3CA Testing Product Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global PD-L1 and PIK3CA Testing Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global PD-L1 and PIK3CA Testing Product Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global PD-L1 and PIK3CA Testing Product Manufacturers, Product Type & Application Table 13. Global PD-L1 and PIK3CA Testing Product Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global PD-L1 and PIK3CA Testing Product by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PD-L1 Table 17. Major Manufacturers of PIK3CA Table 18. Global PD-L1 and PIK3CA Testing Product Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global PD-L1 and PIK3CA Testing Product Sales by Type (2021-2026) & (K Units) Table 20. Global PD-L1 and PIK3CA Testing Product Sales by Type (2027-2032) & (K Units) Table 21. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Type (2021-2026) Table 22. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Type (2027-2032) Table 23. Global PD-L1 and PIK3CA Testing Product Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global PD-L1 and PIK3CA Testing Product Revenue by Type (2021-2026) & (K Units) Table 25. Global PD-L1 and PIK3CA Testing Product Revenue by Type (2027-2032) & (K Units) Table 26. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Type (2021-2026) Table 27. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Diagnostic Center Table 30. Major Manufacturers of Others Table 31. Global PD-L1 and PIK3CA Testing Product Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global PD-L1 and PIK3CA Testing Product Sales by Application (2021-2026) & (K Units) Table 33. Global PD-L1 and PIK3CA Testing Product Sales by Application (2027-2032) & (K Units) Table 34. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Application (2021-2026) Table 35. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Application (2027-2032) Table 36. Global PD-L1 and PIK3CA Testing Product Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global PD-L1 and PIK3CA Testing Product Revenue by Application (2021-2026) & (K Units) Table 38. Global PD-L1 and PIK3CA Testing Product Revenue by Application (2027-2032) & (K Units) Table 39. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Application (2021-2026) Table 40. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Application (2027-2032) Table 41. Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global PD-L1 and PIK3CA Testing Product Sales by Region (2021-2026) & (K Units) Table 43. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Region (2021-2026) Table 44. Global PD-L1 and PIK3CA Testing Product Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global PD-L1 and PIK3CA Testing Product Sales Forecasted Market Share by Region (2027-2032) Table 46. North America PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America PD-L1 and PIK3CA Testing Product Sales by Country (2021-2026) & (K Units) Table 48. North America PD-L1 and PIK3CA Testing Product Sales by Country (2027-2032) & (K Units) Table 49. Europe PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe PD-L1 and PIK3CA Testing Product Sales by Country (2021-2026) & (K Units) Table 51. Europe PD-L1 and PIK3CA Testing Product Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific PD-L1 and PIK3CA Testing Product Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific PD-L1 and PIK3CA Testing Product Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Sales by Country (2027-2032) & (K Units) Table 58. Global PD-L1 and PIK3CA Testing Product Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global PD-L1 and PIK3CA Testing Product Revenue by Region (2021-2026) & (US$ Million) Table 60. Global PD-L1 and PIK3CA Testing Product Revenue by Region (2027-2032) & (US$ Million) Table 61. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Region (2021-2026) Table 62. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Region (2027-2032) Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche PD-L1 and PIK3CA Testing Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Roche PD-L1 and PIK3CA Testing Product Product Portfolio Table 67. Roche Recent Development Table 68. QIAGEN Company Information Table 69. QIAGEN Business Overview Table 70. QIAGEN PD-L1 and PIK3CA Testing Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. QIAGEN PD-L1 and PIK3CA Testing Product Product Portfolio Table 72. QIAGEN Recent Development Table 73. Foundation Medicine Company Information Table 74. Foundation Medicine Business Overview Table 75. Foundation Medicine PD-L1 and PIK3CA Testing Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Foundation Medicine PD-L1 and PIK3CA Testing Product Product Portfolio Table 77. Foundation Medicine Recent Development Table 78. EntroGen Company Information Table 79. EntroGen Business Overview Table 80. EntroGen PD-L1 and PIK3CA Testing Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. EntroGen PD-L1 and PIK3CA Testing Product Product Portfolio Table 82. EntroGen Recent Development Table 83. Amoy Diagnostics Company Information Table 84. Amoy Diagnostics Business Overview Table 85. Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Portfolio Table 87. Amoy Diagnostics Recent Development Table 88. Agilent Technologies Company Information Table 89. Agilent Technologies Business Overview Table 90. Agilent Technologies PD-L1 and PIK3CA Testing Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Agilent Technologies PD-L1 and PIK3CA Testing Product Product Portfolio Table 92. Agilent Technologies Recent Development Table 93. ACCB Biotech Company Information Table 94. ACCB Biotech Business Overview Table 95. ACCB Biotech PD-L1 and PIK3CA Testing Product Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. ACCB Biotech PD-L1 and PIK3CA Testing Product Product Portfolio Table 97. ACCB Biotech Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. PD-L1 and PIK3CA Testing Product Distributors List Table 101. PD-L1 and PIK3CA Testing Product Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. PD-L1 and PIK3CA Testing Product Product Image Figure 2. Global PD-L1 and PIK3CA Testing Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PD-L1 and PIK3CA Testing Product Market Size (2021-2032) & (US$ Million) Figure 4. Global PD-L1 and PIK3CA Testing Product Sales (2021-2032) & (K Units) Figure 5. Global PD-L1 and PIK3CA Testing Product Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 PD-L1 and PIK3CA Testing Product Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PD-L1 Image Figure 9. PIK3CA Image Figure 10. Global PD-L1 and PIK3CA Testing Product Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global PD-L1 and PIK3CA Testing Product Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Type (2021-2032) Figure 13. Global PD-L1 and PIK3CA Testing Product Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global PD-L1 and PIK3CA Testing Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Diagnostic Center Image Figure 18. Others Image Figure 19. Global PD-L1 and PIK3CA Testing Product Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global PD-L1 and PIK3CA Testing Product Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global PD-L1 and PIK3CA Testing Product Sales Market Share by Application (2021-2032) Figure 22. Global PD-L1 and PIK3CA Testing Product Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global PD-L1 and PIK3CA Testing Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Application (2021-2032) Figure 25. North America PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America PD-L1 and PIK3CA Testing Product Sales Market Share by Country (2021-2032) Figure 27. U.S. PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe PD-L1 and PIK3CA Testing Product Sales Market Share by Country (2021-2032) Figure 32. Germany PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific PD-L1 and PIK3CA Testing Product Sales Market Share by Country (2021-2032) Figure 39. China PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Sales Market Share by Country (2021-2032) Figure 47. Brazil PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile PD-L1 and PIK3CA Testing Product Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global PD-L1 and PIK3CA Testing Product Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America PD-L1 and PIK3CA Testing Product Revenue (2021-2032) & (US$ Million) Figure 58. North America PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe PD-L1 and PIK3CA Testing Product Revenue (2021-2032) & (US$ Million) Figure 60. Europe PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific PD-L1 and PIK3CA Testing Product Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. PD-L1 and PIK3CA Testing Product Value Chain Figure 66. Manufacturing Cost Structure Figure 67. PD-L1 and PIK3CA Testing Product Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • PD-L1
  • PIK3CA
Applications
  • Hospital
  • Diagnostic Center
  • Others
Companies covered
  • Roche
  • QIAGEN
  • Foundation Medicine
  • EntroGen
  • Amoy Diagnostics
  • Agilent Technologies
  • ACCB Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PD-L1 and PIK3CA Testing Product Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PD-L1 and PIK3CA Testing Product Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global PD-L1 and PIK3CA Testing Product Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global PD-L1 and PIK3CA Testing Product Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global PD-L1 and PIK3CA Testing Product Market Dynamics
  1. 2.1 PD-L1 and PIK3CA Testing Product Industry Trends
  2. 2.2 PD-L1 and PIK3CA Testing Product Industry Drivers
  3. 2.3 PD-L1 and PIK3CA Testing Product Industry Opportunities and Challenges
  4. 2.4 PD-L1 and PIK3CA Testing Product Industry Restraints
3 PD-L1 and PIK3CA Testing Product Market by Manufacturers
  1. 3.1 Global PD-L1 and PIK3CA Testing Product Revenue by Manufacturers (2021-2026)
  2. 3.2 Global PD-L1 and PIK3CA Testing Product Sales by Manufacturers (2021-2026)
  3. 3.3 Global PD-L1 and PIK3CA Testing Product Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global PD-L1 and PIK3CA Testing Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PD-L1 and PIK3CA Testing Product Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global PD-L1 and PIK3CA Testing Product Manufacturers, Product Type & Application
  7. 3.7 Global PD-L1 and PIK3CA Testing Product Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PD-L1 and PIK3CA Testing Product Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PD-L1 and PIK3CA Testing Product Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PD-L1 and PIK3CA Testing Product Tier 1, Tier 2, and Tier 3
4 PD-L1 and PIK3CA Testing Product Market by Type
  1. 4.1 PD-L1 and PIK3CA Testing Product Type Introduction
  2. 4.1.1 PD-L1
  3. 4.1.2 PIK3CA
  4. 4.2 Global PD-L1 and PIK3CA Testing Product Sales by Type
  5. 4.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global PD-L1 and PIK3CA Testing Product Sales by Type (2021-2032)
  7. 4.2.3 Global PD-L1 and PIK3CA Testing Product Sales Market Share by Type (2021-2032)
  8. 4.3 Global PD-L1 and PIK3CA Testing Product Revenue by Type
  9. 4.3.1 Global PD-L1 and PIK3CA Testing Product Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global PD-L1 and PIK3CA Testing Product Revenue by Type (2021-2032)
  11. 4.3.3 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Type (2021-2032)
5 PD-L1 and PIK3CA Testing Product Market by Application
  1. 5.1 PD-L1 and PIK3CA Testing Product Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Diagnostic Center
  4. 5.1.3 Others
  5. 5.2 Global PD-L1 and PIK3CA Testing Product Sales by Application
  6. 5.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PD-L1 and PIK3CA Testing Product Sales by Application (2021-2032)
  8. 5.2.3 Global PD-L1 and PIK3CA Testing Product Sales Market Share by Application (2021-2032)
  9. 5.3 Global PD-L1 and PIK3CA Testing Product Revenue by Application
  10. 5.3.1 Global PD-L1 and PIK3CA Testing Product Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global PD-L1 and PIK3CA Testing Product Revenue by Application (2021-2032)
  12. 5.3.3 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Application (2021-2032)
6 Global PD-L1 and PIK3CA Testing Product Sales by Region
  1. 6.1 Global PD-L1 and PIK3CA Testing Product Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PD-L1 and PIK3CA Testing Product Sales by Region (2021-2032)
  3. 6.2.1 Global PD-L1 and PIK3CA Testing Product Sales by Region (2021-2026)
  4. 6.2.2 Global PD-L1 and PIK3CA Testing Product Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global PD-L1 and PIK3CA Testing Product Revenue by Region
  1. 7.1 Global PD-L1 and PIK3CA Testing Product Revenue by Region
  2. 7.1.1 Global PD-L1 and PIK3CA Testing Product Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global PD-L1 and PIK3CA Testing Product Revenue by Region (2021-2026)
  4. 7.1.3 Global PD-L1 and PIK3CA Testing Product Revenue by Region (2027-2032)
  5. 7.1.4 Global PD-L1 and PIK3CA Testing Product Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America PD-L1 and PIK3CA Testing Product Revenue (2021-2032)
  8. 7.2.2 North America PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe PD-L1 and PIK3CA Testing Product Revenue (2021-2032)
  11. 7.3.2 Europe PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific PD-L1 and PIK3CA Testing Product Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa PD-L1 and PIK3CA Testing Product Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche PD-L1 and PIK3CA Testing Product Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche PD-L1 and PIK3CA Testing Product Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 QIAGEN
  8. 8.2.1 QIAGEN Company Information
  9. 8.2.2 QIAGEN Business Overview
  10. 8.2.3 QIAGEN PD-L1 and PIK3CA Testing Product Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 QIAGEN PD-L1 and PIK3CA Testing Product Product Portfolio
  12. 8.2.5 QIAGEN Recent Developments
  13. 8.3 Foundation Medicine
  14. 8.3.1 Foundation Medicine Company Information
  15. 8.3.2 Foundation Medicine Business Overview
  16. 8.3.3 Foundation Medicine PD-L1 and PIK3CA Testing Product Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Foundation Medicine PD-L1 and PIK3CA Testing Product Product Portfolio
  18. 8.3.5 Foundation Medicine Recent Developments
  19. 8.4 EntroGen
  20. 8.4.1 EntroGen Company Information
  21. 8.4.2 EntroGen Business Overview
  22. 8.4.3 EntroGen PD-L1 and PIK3CA Testing Product Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 EntroGen PD-L1 and PIK3CA Testing Product Product Portfolio
  24. 8.4.5 EntroGen Recent Developments
  25. 8.5 Amoy Diagnostics
  26. 8.5.1 Amoy Diagnostics Company Information
  27. 8.5.2 Amoy Diagnostics Business Overview
  28. 8.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Product Portfolio
  30. 8.5.5 Amoy Diagnostics Recent Developments
  31. 8.6 Agilent Technologies
  32. 8.6.1 Agilent Technologies Company Information
  33. 8.6.2 Agilent Technologies Business Overview
  34. 8.6.3 Agilent Technologies PD-L1 and PIK3CA Testing Product Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Agilent Technologies PD-L1 and PIK3CA Testing Product Product Portfolio
  36. 8.6.5 Agilent Technologies Recent Developments
  37. 8.7 ACCB Biotech
  38. 8.7.1 ACCB Biotech Company Information
  39. 8.7.2 ACCB Biotech Business Overview
  40. 8.7.3 ACCB Biotech PD-L1 and PIK3CA Testing Product Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ACCB Biotech PD-L1 and PIK3CA Testing Product Product Portfolio
  42. 8.7.5 ACCB Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PD-L1 and PIK3CA Testing Product Value Chain Analysis
  2. 9.1.1 PD-L1 and PIK3CA Testing Product Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PD-L1 and PIK3CA Testing Product Production Mode & Process
  6. 9.2 PD-L1 and PIK3CA Testing Product Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PD-L1 and PIK3CA Testing Product Distributors
  9. 9.2.3 PD-L1 and PIK3CA Testing Product Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.